Development and Characterization of Mucoadhesive Microspheres Containing a Model Antidiabetic Drug

Authors

  • Mudit Dixit NGSM Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India
  • R. Narayana Charyulu NGSM Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India
  • Sompalli Prashanthi NGSM Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India
  • Nisha G. Shetty NGSM Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India

Abstract

The present work was envisaged to reduce the dosing frequency and improve patient compliance by designing and evaluating sustained release mucoadhesive (SRM) microspheres of metformin hydrochloride (MH) for an effective control of diabetes type-2. Microspheres were prepared by emulsification solvent evaporation method using sodium alginate, carbopol 934P (CP), and sodium carboxy methyl cellulose (SCMC) as a mucoadhesive polymers. The microspheres exhibits good mucoadhesive properties and showed high drug entrapment efficiency. MH release from these microspheres was slow and extended and dependent on the type of polymer used. The data obtained thus suggest that mucoadhesive microspheres can be successfully designed for sustained delivery of metformin hydrochloride and to improve patient compliance.

 

Keywords: Microspheres, diabetes mellitus type-2, mucoadhesion, controlled drug release, sodium alginate, carbopol, sodium carboxy methyl cellulose

Cite this Article

Charyulu R Narayana, Prashanthi Sompalli, Dixit Mudit, et al. Development and characterization of mucoadhesive microspheres containing a model antidiabetic drug. Research & Reviews: A Journal of Drug Design & Discovery. 2015; 2(2): 12–19p.

Downloads

Published

2019-03-01

Issue

Vol. 2 No. 2 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.